Brief: scPharmaceuticals Inc Announces FDA Acceptance Of Furoscix New Drug Application
May 16 (Reuters) - scPharmaceuticals Inc SCPH.O :
* SCPHARMACEUTICALS INC. ANNOUNCES FDA ACCEPTANCE OF
FUROSCIX® NEW
DRUG APPLICATION
* SCPHARMACEUTICALS INC - PDUFA ACTION DATE SET FOR OCTOBER
8,
2022
* SCPHARMACEUTICALS INC - PREPARING FOR Q4 COMMERCIAL
LAUNCH, IF
APPROVED
Source text for Eikon: ID:nGNX28Rhgn
Further company coverage: SCPH.O